Analytical Data
-
Gene name
FAM124B
- Application
-
Alternative Names
FAM124B；Protein FAM124B
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9H5Z6
-
Expression Region
1-455aa
-
AA Sequence
MDETQGPLAMTVHLLANSGHGSLLQRTLDQLLDCICPEVRLFQVSERASPVKYCEKSHSKRSRFPGMSVLLFLHESPGEDRLFRVLDSLQHSPWQCYPTQDTRGRLCPYFFANQEFYSLDSQLPIWGVRQVHCGSEILRVTLYCSFDNYEDAIRLYEMILQREATLQKSNFCFFVLYASKSFALQLSLKQLPPGMSVDPKESSVLQFKVQEIGQLVPLLPNPCMPISSTRWQTQDYDGNKILLQVQLNPELGVKNGILGAGMLPLGSRLTSVSAKRTSEPRSQRNQGKRSQGHSLELPEPSGSPTSDRCAGTSWKSPGRSFQVSSPAMGAHLHLSSHHLESGARMKVLNRENSFQKLEAETNVDTGLTIINSEPRQTYFGGFPRDLQTSQPPFCLPASSLGVATSKNNSVLKERVSPLPLAGQRDLGTRKTISECLLHLQVQGEEKEEDEEEFFI
-
Molecular Weight
56.9 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FAM124B, a member of the family of proteins associated with diverse biological functions, has garnered attention in recent years due to its potential roles in cellular processes and implications in various diseases. Originally identified through genomic studies, FAM124B is implicated in cellular localization and trafficking, influencing the organization of cellular components. Research suggests that FAM124B may play a crucial role in modulation of immune responses, and its dysregulation has been linked to diseases such as cancer and neurodegenerative disorders. The exploration of FAM124B as a recombinant protein holds promise for elucidating its biological functions and mechanisms. By generating and characterizing recombinant FAM124B, researchers aim to understand its structure-function relationships and interactions with other cellular proteins. Furthermore, investigating its potential as a therapeutic target or biomarker in disease contexts underscores the significance of this protein in biomedical research. Advances in recombinant protein technology enable the production of FAM124B in suitable expression systems, facilitating detailed studies on its biochemical properties and biological activities. Overall, the study of FAM124B as a recombinant protein provides insights that could lead to novel strategies in disease management and therapeutic development.
